Group One Trading
ANTH

Group One Trading’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Group One Trading’s Portfolio ANTH Stock Details ANTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-21,525
Closed -$73K – 5366
2017
Q1 		$73K Buy
21,525
+4,812
+29% +$22.8K ﹤0.01% 3187
2016
Q4 		$87K Buy
16,713
+4,025
+32% +$69.7K ﹤0.01% 2921
2016
Q3 		$320K Buy
12,688
+12,000
+1,744% +$303K ﹤0.01% 2150
2016
Q2 		$17K Sell
688
-337
-33% -$9.52K ﹤0.01% 3878
2016
Q1 		$30K Sell
1,025
-7,338
-88% -$199K ﹤0.01% 3541
2015
Q4 		$310K Sell
8,363
-2,237
-21% -$98.7K ﹤0.01% 2178
2015
Q3 		$516K Buy
10,600
+8,762
+477% +$612K 0.01% 1758
2015
Q2 		$127K Buy
1,838
+488
+36% +$22.6K ﹤0.01% 2896
2015
Q1 		$48K Buy
1,350
+1,100
+440% +$32.6K ﹤0.01% 3393
2014
Q4 		$3K Sell
250
-375
-60% -$5.45K ﹤0.01% 4639
2014
Q3 		$10K Buy
625
+87
+16% +$1.83K ﹤0.01% 4484
2014
Q2 		$15K Buy
+538
New +$13.3K ﹤0.01% 4343

Other funds holding ANTH

WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Group One Trading's ANTH Position: Q2 2018 in Review

Group One Trading sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q2 2018, closing a stake of 2,361 shares — an estimated $1K sold.

Group One Trading first reported a position in ANTH in Q1 2014 and held it in 11 quarters. The position peaked at $402K in Q3 2015. 5 funds tracked by Wall St. Rank hold ANTH as of Q2 2018.

  • Group One Trading reported no remaining Anthera Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
  • Group One Trading sold 2,361 Anthera Pharmaceuticals, Inc. shares in Q2 2018, an estimated $1K.
  • Group One Trading first reported a position in Anthera Pharmaceuticals, Inc. in Q1 2014 and held it in 11 quarters.
  • Group One Trading's Anthera Pharmaceuticals, Inc. position peaked at $402K in Q3 2015.
  • 5 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q2 2018.

Based on Group One Trading's 13F filing for Q2 2018, filed 14 Aug 2018.